You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
崑崙萬維(300418.SZ):參投公司心通醫療成功在港上市
格隆匯 02-04 18:15

格隆匯 2 月 4日丨崑崙萬維(300418.SZ)公佈,2021年2月4日,微創心通醫療科技有限公司(“心通醫療”)在香港聯交所主板成功上市,股票代碼“2160.HK”。公司的全資子公司崑崙集團有限公司作為基石投資人,出資500萬美元持有心通醫療317.7萬股。

心通醫療成立於2015年,是微創醫療科學有限公司(股票代碼:00853.HK)旗下子公司,專注於心髒瓣膜疾病領域創新的經導管及手術解決方案的研發和商業化。旗下已有三種產品上市,分別為VitaFlowTM、AlwideTM瓣膜球囊擴張導管及AlpassTM導管鞘。公司投資心通醫療,是公司把握優質賽道,繼續踐行立足互聯網核心業務,投資互聯網AI(物聯網和人工智能)發展戰略的重要舉措。

心通醫療上市後,公司將按照企業會計準則的規定進行相關資產的計量,心通醫療在資產負債表日的股票收盤價將作為公司確認其公允價值的重要依據。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account